A Study to Evaluate the Efficacy of Bortezomib based Multiple Therapeutic Modalities for Donor Specific Antibody Treatment in Patients Who Underwent Lung Transplant.
Phase of Trial: Phase IV
Latest Information Update: 21 Aug 2015
At a glance
- Drugs Bortezomib (Primary) ; Rituximab
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 21 Aug 2015 New trial record